Melanoma Inhibitor of Apoptosis Protein (ML-IAP) Is a Target for Immune-Mediated Tumor Destruction

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0530311100
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

X-Linked Inhibitor of Apoptosis Protein as a Therapeutic Target in Metastatic Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2010English

RIP1 Is Required for IAP Inhibitor-Mediated Sensitization of Childhood Acute Leukemia Cells to Chemotherapy-Induced Apoptosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

TAK1 Is a Pivotal Therapeutic Target for Tumor Progression and Bone Destruction in Myeloma

Haematologica
Hematology
2020English

Inhibitor of Apoptosis (IAP) Proteins as Drug Targets for the Treatment of Cancer

F1000 Biology Reports
2009English

MOZ–TIF2-mediated Destruction of CBP/p300 Is Blocked by Calpain Inhibitor 2

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Disialoganglioside GD3 on Human Melanoma Serves as a Relevant Target Antigen for Monoclonal Antibody-Mediated Tumor Cytolysis.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1985English

Ribosomal Protein S27L Is a Direct P53 Target That Regulates Apoptosis

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

TheDrosophilaInhibitor of Apoptosis (IAP) DIAP2 Is Dispensable for Cell Survival, Required for the Innate Immune Response to Gram-Negative Bacterial Infection, and Can Be Negatively Regulated by the Reaper/Hid/Grim Family of IAP-binding Apoptosis Inducers

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis

Current Medicinal Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular MedicinePharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy